Stem Cell Assays Market Worth $4.5 Billion by 2027 - Exclusive Report by MarketsandMarkets™
- In January 2022, Agilent Technologies Inc. launched Seahorse XF Pro Analyzer, enabling operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fate, fitness, and function.
View full press release